Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo

Published:2015-02-24 Issue:5 Volume:46 Page:2172-2180
ISSN:1019-6439
Container-title:International Journal of Oncology
language:en
Short-container-title:

Author:

FUJIHARA SHINTARO,KATO KIYOHITO,MORISHITA ASAHIRO,IWAMA HISAKAZU,NISHIOKA TOMOKO,CHIYO TAIGA,NISHIYAMA NORIKO,MIYOSHI HISAAKI,KOBAYASHI MITSUYOSHI,KOBARA HIDEKI,MORI HIROHITO,OKANO KEIICHI,SUZUKI YASUYUKI,MASAKI TSUTOMU

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases;Medicine International;2024-06-19

2. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect;Translational Oncology;2024-06

3. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights;International Journal of Molecular Sciences;2024-03-04

4. Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo;Cancers;2023-09-28

5. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study;JNCI Cancer Spectrum;2023-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP